Role of p53 mutations on survival after pancreatoduodenectomy for ductal adenocarcinoma of the pancreatic head

Hepato-Gastroenterology

Volumn 48, Issue 42, 2001, Pages 1743-1745

  Gazzaniga, G M ^a   Papadia, F S ^a   Dezzana, M ^a   Cappato, S ^a   Filauro, M ^a   Bandelloni, R ^a  

^a NONE   (Italy)

Author keywords

P53; Pancreatic cancer

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREATICODUODENECTOMY; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

AGED; CARCINOMA, DUCTAL, BREAST; FEMALE; GENES, P53; HUMANS; MALE; MUTATION; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0035658591     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. General aspects of surgical treatment of pancreatic cancer
2. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients
3. Mutations in the p53 gene occur in diverse human tumours types
4. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases
5. The p53 tumour suppressor gene
6. Evaluation of PCNA, p53, K-ras and LOH inendocrine pancreas tumors
7. p53 expression affects the efficacy of adjuvant chemotherapy after resection of invasive ductal carcinoma of the pancreas
8. bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: Association with clinical outcome
9. Ki-ras codon 12 point and P53 mutations: A molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer